logo
Plus   Neg
Share
Email

Astellas Pharma Gets Positive CHMP Opinion For XOSPATA

Astellas Pharma Inc. said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA has adopted a positive opinion recommending the oral once-daily therapy XOSPATA or gilteritinib as a monotherapy for the treatment of adult patients who have relapsed or refractory (resistant to treatment) acute myeloid leukemia or AML with a FLT3 mutation (FLT3mut+).

If approved by the European Commission, gilteritinib has the potential to improve treatment outcomes for AML patients with the most common mutations - FLT3 internal tandem duplication (ITD) and FLT3 tyrosine kinase domain (TKD) - and would be one of the few advances for the treatment of AML in Europe over the past 40 years.

Gilteritinib received accelerated assessment from the EMA, which allowed the CHMP to reduce the timeframe for approval.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Bed Bath & Beyond, Inc. is planning to close around 200 mostly Bed Bath & Beyond stores over the next two years amid continuing struggles with Covid-19. The home improvement retailer, which reported a wider-than-expected loss in its first quarter with sharply lower sales, said the move is part of its plans to right-size its real estate portfolio and to cut costs. United Airlines has warned that 36,000 employees or about 45% of its U.S. workforce could be furloughed in October, due to continuing losses caused by the coronavirus pandemic and collapse in air travel, according to reports citing the company's memo sent to employees. Walmart is planning to launch a new subscription program, Walmart+, in late July, according to a report by Recode. The new membership program, which is likely to be direct competitor to Amazon Prime, will cost $98 per year. Walmart+ is expected to include fuel discounts at Walmart gas stations, unlimited same-day delivery of groceries and general merchandise from Walmart Supercenters...
RELATED NEWS
Follow RTT